Positive Results For ViroPharma Drug Trial
ViroPharma Inc. (VPHM) reported positive results for its early stage trial of HCV-796, a hepatitis C treatment. The stock price surged $1.44 to close at $12.61.
posted by FC Market News at 10:50 AM
0 Comments:
Post a Comment
<< Home